Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-25-010730
Filing Date
2025-04-02
Accepted
2025-04-02 17:17:25
Documents
117
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K nby20241231_10k.htm   iXBRL 10-K 3039348
2 EXHIBIT 4.1 ex_793560.htm EX-4.1 16616
3 EXHIBIT 19 ex_792676.htm EX-19 93951
4 EXHIBIT 21 ex_794259.htm EX-21 1464
5 EXHIBIT 23.1 ex_796545.htm EX-23.1 3409
6 EXHIBIT 31.1 ex_794260.htm EX-31.1 8499
7 EXHIBIT 31.2 ex_794261.htm EX-31.2 8491
8 EXHIBIT 32.1 ex_794262.htm EX-32.1 4677
9 EXHIBIT 32.2 ex_794263.htm EX-32.2 4313
15 novalogosm.jpg GRAPHIC 14118
  Complete submission text file 0001437749-25-010730.txt   15673283

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA nby-20241231.xsd EX-101.SCH 134340
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20241231_def.xml EX-101.DEF 896970
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20241231_lab.xml EX-101.LAB 681638
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20241231_pre.xml EX-101.PRE 941412
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nby-20241231_cal.xml EX-101.CAL 70241
120 EXTRACTED XBRL INSTANCE DOCUMENT nby20241231_10k_htm.xml XML 3132773
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33678 | Film No.: 25806084
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)